RESUMO

In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues.

Assuntos

COVID-19/epidemiologia , COVID-19/terapia , Internacionalidade , Esclerose Múltipla/epidemiologia , Esclerose Múltipla/terapia , Guias de Prática Clínica como Assunto/normas , Gerenciamento Clínico , Humanos , Pandemias/prevenção & controle , Farmacovigilância , Telemedicina/normas , Telemedicina/tendências